icobrain
icobrain is intended for automatic labeling visualization and volumetric quantification of segmentable brain structures from a set of MR or noncontrast CT (NCCT) images.
- MR
- MRI
- CT
- volumetric quantification
- AI
- segmentation
- multiple sclerosis
- dementia
- TBI
- traumatic brain injury
Automate the current manual process of identifying, labeling and quantifying the volume of segmentable brain structures identified on MR and NCCT (non-contrast CT) images.
The output of each icobrain evaluation consists of a concise report with normative reference values and color-coded segmentations in DICOM format to help the radiologist and neurologist interpret and communicate the patient's condition.
Augmented productivity due to 60% faster reporting1
1Sima, D; Wilms, G; Vande Vyvere, T; Van Hecke, W; Smeets, D; Leuven/BE; Leuven, Be/BE; icometrix, Belgium/BE; Not applicable, Retrospective, Image verification, Computer Applications-Detection, diagnosis, MR, Neuroradiology brain, Artificial Intelligence and Machine Learning, Multicentre study; ECR 2020. Retrieved March 27, 2023 from https://epos.myesr.org/poster/esr/ecr2020/C-11342
Increases consistency
icobrain ms structured report increases consistency (reduced intra rater variablity among assistant neurologists)1,2
1Struyfs H, Sima DM, Wittens M, Ribbens A, Pedrosa de Barros N, Phan TV, Ferraz Meyer MI, Claes L, Niemantsverdriet E, Engelborghs S, Van Hecke W, Smeets D. Automated MRI volumetry as a diagnostic tool for Alzheimer's disease: Validation of icobrain dm. Neuroimage Clin. 2020;26:102243. doi: 10.1016/j.nicl.2020.102243. Epub 2020 Mar 12. PMID: 32193172; PMCID: PMC7082216.
2Sima, D; Wilms, G; Vande Vyvere, T; Van Hecke, W; Smeets, D; Leuven/BE; Leuven, Be/BE; icometrix, Belgium/BE; Not applicable, Retrospective, Image verification, Computer Applications-Detection, diagnosis, MR, Neuroradiology brain, Artificial Intelligence and Machine Learning, Multicentre study; ECR 2020. Retrieved March 27, 2023 from https://epos.myesr.org/poster/esr/ecr2020/C-11342
icobrain DM
icobrain DM for MR and CT
icobrain dm is intended to automate the current manual process of identifying, labeling, and quantifying the volume of segmentable brain structures identified on MR or NCCT images. For MR images icobrain dm uncovers abnormality patterns by 1) Assessing the total FLAIR lesion burden and 2) Comparing whole brain and ventricular volumes to an age-and gender matched normative healthy population. For NCCT images icobrain dm uncovers abnormality patterns by comparing whole brain and ventricular volumes to an age- and gender matched normative healthy population.
icobrain MS
icobrain ms: Cloud-based Al solution to help MS care teams deliver personalized care for patients with multiple sclerosis.
This application is an Al solution for the volumetric quantification of brain MRI scans in clinical practice.
- Population graph shows the ageand gender-matched median and normal range for the whole brain and gray matter volume of healthy people.
- Apply treatment scoring in routine (Rio, NEDA-3, NEDA-4, Rio-4)
- Exercise Shared Decision Making
- Assess treatment adherence
icobrain TBI
icobrain TBI for MR and CT
icobrain tbi produces reports that can be useful when evaluating potential traumatic brain injury patients. For MR images icobrain TBI uncovers abnormality patterns by 1) Detecting and quantifying FLAIR white matter hyperintensities and 2) Comparing brain volumes to an age and gender matched normative healthy population. For NCCT images icobrain TBI allows for the detection of mass effects by: 1) Detecting, quantifying and classifying hyperdensities (epidural, subdural and intra parenchymal). 2) Assessing the CSF spaces (ventricular and cisternal spaces) and ventricular asymmetry. 3) Measuring midline shift. 4) Visualizing CSF space patterns in an intuitive bull's eye graph. 5) Comparing volumes to an age-and gender matched normative healthy population
References
- lcometrix HCP Manual icobrian MR 5.0.5x doc. 158313995.45
- icometrix Manual - Report Interpretation
- FDA premarket notification K192130
- Sima et al, ECR 2020, Poster C-11342 RESULTS
- Van Hecke et al, Novel Digital Care Management Platform in MS, Brain Sci, 2021
What Customers Are Saying
"icobrain provides reliable MRI analysis allowing me to instantly track the disease progression of our patients with a neurological disorder."
Vitazoslav Belan, Dr Magnet Kramare,
at Pro Diagnostic Group, Slovakia
May not reflect a typical user experience; actual results may vary.
What Customers Are Saying
"We use icobrain for quantifying lesions on our routine MRIs. In this work, the analysis of icometrix serves as an unbiased second opinion."
Mrs. Shilpa
Neuroradiologist at Picture This by Jankharia Imaging Center India
May not reflect a typical user experience; actual results may vary.
What Customers Are Saying
"Like icobrain, brain biomarker measurements need to be extremely reproducible and sensitive enough to detect relevant clinical changes."
Dr. Max Wintermark
Professor of Radiology and Chief of Neuroradiology at Stanford University Medical Center USA
May not reflect a typical user experience; actual results may vary.
What Customers Are Saying
"I feel like icobrain's AI is better at diagnosing hippocampal loss compared to visual rating. Whilst with the volumetric report, we clearly see a hippocampal loss, we could not identify this by visual assessment (MTA-score)."
De Roeck
MD Radiologist at AZ Herentals
May not reflect a typical user experience; actual results may vary.
What Customers Are Saying
"icobrain ms has been a really valuable addition to our clinical practice as patients can conceptually understand much better what we are looking for in their brain scans."
Jeffrey Dunn,
MD, MS Neurologist
May not reflect a typical user experience; actual results may vary.
See Ahead for Yourself